Microbot Medical Inc. announced that Ripal T. Gandhi, MD, FSVM, will join the Company's robust Scientific Advisory Board (SAB). Dr. Gandhi is an interventional oncologist and a member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team where he specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases, and has a history of being an innovator in the Interventional Robotics field. Dr. Ripal Gandhi is experienced in treating cancers, peripheral arterial disease (PAD), thoracic aortic aneurysms, abdominal aortic aneurysms (AAA), uterine fibroids, deep venous thrombosis, pulmonary embolism, varicoceles, and varicose veins.Dr. Gandhi is a clinical professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine, training physicians in vascular/endovascular, interventional radiology and interventional oncology techniques.

While at Memorial Sloan-Kettering, he investigated hepatic embolization and other minimally invasive therapies for liver cancer and other malignancies. Dr. Gandhi received his medical degree from Northwestern University Medical School, completed surgical internships at Cornell University Medical Center and NY Presbyterian Hospital, followed by residency training and fellowship at UCLA Medical Center. Dr. Gandhi is the recipient of multiple awards, co-authored the textbook Interventional Oncology, and is a fellow of the Society of Vascular Medicine, Society of Interventional Radiology and a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).